Voyager Acquisition Corp Unit (VACHU)

VERAXA Biotech, an emerging leader in cancer therapies, is attending the ASCO and BIO conferences to showcase its BiTAC platform and meet with potential partners and investors. The company is preparing to list on the NASDAQ later this year.